10 Abstract INTRODUCTION: Vaccination is the only way to achieve group immunity in the SARS CoV-2 pandemic. Efforts to create safe vaccines worldwide have led to 60 vaccines being clinically evaluated at the moment according to the WHO, and the European Medicines Agency has urgently authorized the BioNTech / Fosun Pharma / Pfizer vaccine, a vaccine based on the mRNA technique. OBJECTIVES: The study looks at the accepta- bility and intent of COVID-19 vaccination among medical staff. MATERIAL AND METHODS: The study was conducted between November 3 rd and November 12 th 2020, by distributing an anonymous questionnaire in online professional groups of medical staff regarding the acceptance of vaccination in general, and vaccina- tion against COVID-19 in particular. RESULTS: 612 persons answered to the sur- vey, 164 nurses and 448 doctors. 207 doctors work in the hospitals, 103 in ambu- latory care clinics, 76 in school medical offices and 62 in family doctors offices. 565 respondents (92,3%) support vaccination in general, while 47 (7,7%) do not. 43,3% of the medical staff that were a part of this study were vaccinated against influenza this season. 80% of the medical staff supports vaccination against COVID-19, in general, and 47% of the respondents state that they will get vaccinated against COVID-19. CONCLUSIONS: The Romanian medical staff supports the vaccination against COVID-19, and the safe vaccination intention is 47%. KEY WORDS: vaccination intention, anti COVID-19 vaccination, medical personnel INTRODUCTION The installation of group immunity in SARS- CoV-2 infection is estimated at 67%. There are two possibilities to achieve widespread immunity against SARS-CoV-2: (1) a mass vaccination campaign, with safe vaccines, or (2) the natural immunization of the population, over time. But the consequences of the latter are extremely serious, as it involves mass infec- tion of the population and millions of deaths [1]. A study on survivors of SARS-CoV-2 infec- tion, persons that needed hospital admission for their illness, showed that approximately 90% have protec- tive antibodies and approximately 50% have a strong T lymphocyte response. Nevertheless, studies on out- patients are needed in order to assess the level of pro- tective antibodies after mild infections [2]. In this context, the urgency of discovering a vaccine effective against COVID-19 is very high, and research for the production of a vaccine are nu- merous worldwide. However, the safety of citizens remains a key priority, so the European Commission considers that quality, safety and efficacy standards in the authorization of these vaccines must be strictly adhered to [3]. According to the World Health Organization, on 29.12.2020 there were 60 vaccines worldwide in the clinical evaluation stage and 172 vaccines in the pre-clinical evaluation stage [4]. The types of candi- date vaccines in the clinical evaluation stage are pre- sented in Table no. 1, and a classification according to the number of doses and the route of administration – in Table no. 2. Journal of School and University Medicine, Vol VII, No. 4, october-december 2020 THE ANTI COVID-19 VACCINATION INTENTION OF MEDICAL PERSONNEL FROM ROMANIA Dr. Daniela Rajka, Cluj-Napoca school medical office * Corresponding author: Daniela Rajka, Cluj-Napoca school medical office, e-mail: rajkadani07@yahoo.com Article received: 31.12.2020, accepted: 4.01.2021, published: 10.01.2021 Citing: Rajka D. Journal of School and University Medicine 2020;7(4):10-16